Age-Dependent Regression of M-MSV Tumors in CBA/H Mice: Requirement for a Macrophage-Adherent Cell Population

  • O. Stutman
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 73B)


The effects of aging on immune responses in mice are complex and show some remarkable genetic influences (8,12,13,17,20,21,24, 25, 26,28). Certain strains will show profound impairment of both humoral as well as cellular immunity with increasing age, while other strains will have only moderate decline of immune functions (8,12,13,17,20,21,24,25,26,28). With the exception of the autoimmune-susceptible mouse strains which show a precocious decline of T-dependent functions and cell-mediated immunity (17,20,21,24, 25,28) it is accepted that cell-mediated immunity, measured both in vivo and in vitro, shows less impairment than humoral immunity, especially in long-lived non-autoimmune strains (8,12,13,17,20,21, 25). A good example of such a situation is the CBA/H subline, which is long-lived, does not show any detectable signs of “NZB-type” autoimmune disease (21,25), shows normal levels of T-dependent lymphocytes (20,21), shows intact thymus function (24,28) and a remarkable preservation of immune responses, especially cell-mediated immunity, even at advanced age, beyond the 10% survival range (17,21,25).


Spleen Cell Profound Impairment Immunological Nature Basic Experimental Model Remarkable Preservation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bubenik, J. and Turano, A., Folia Biol., 14 (1968) 433.Google Scholar
  2. 2.
    Collavo, D., Colombatti, A., Chieco-Bianchi, L. and Davies, A.J.S., Nature, 249 (1974) 169.PubMedCrossRefGoogle Scholar
  3. 3.
    DeClerq, E., J. Nat. Cancer Inst., 54 (1975) 473.Google Scholar
  4. 4.
    East, J. and Harvey, J.J., Int. J. Cancer, 3 (1968) 614.PubMedCrossRefGoogle Scholar
  5. 5.
    Fefer, A., McCoy, J.L. and Glynn, J.P., Cancer Res., 27 (1967) 1626.PubMedGoogle Scholar
  6. 6.
    Fefer, A., McCoy, J.L. and Glynn, J.P., Cancer Res., 27 (1967) 2207.PubMedGoogle Scholar
  7. 7.
    Fefer, A., Cancer Res., 29 (1969) 2177.PubMedGoogle Scholar
  8. 8.
    Gerbase-deLima, M., Meredith, P. and Walford, R.L., Fed. Proc., 34 (1975) 159.PubMedGoogle Scholar
  9. 9.
    Lamon, E.W., Skurzak, H.M., Klein, E. and Wigzell, H., J. Exp. Med., 136 (1972) 1072.PubMedCrossRefGoogle Scholar
  10. 10.
    Law, L.W., Ting, R.C. and Allison, A.C., Nature, 220 (1968) 611.CrossRefGoogle Scholar
  11. 11.
    Law, L.W., Ting, R.C. and Stanton, M.F., J. Nat. Cancer Inst., 40 (1968) 1101.PubMedGoogle Scholar
  12. 12.
    Makinodan, T. and Adler, W.H., Fed. Proc, 34 (1975) 153.PubMedGoogle Scholar
  13. 13.
    Nordin, A.A. and Makinodan, T., Fed. Proc, 33 (1974) 2033.PubMedGoogle Scholar
  14. 14.
    Owen, J.J.T and Seeger, R.C, Brit. J. Cancer 28, Suppl. I, (1973) 26.Google Scholar
  15. 15.
    Pazmino, N.H. and Yuhas, J.M., Cancer Res., 33 (1973) 2668.PubMedGoogle Scholar
  16. 16.
    Plata, F., Gomard, E., Leclerc, J.C. and Levy, J.P., J. Immunol. 111 (1973) 667.PubMedGoogle Scholar
  17. 17.
    Rodey, G.E., Good, R.A. and Yunis, E.J., Clin. Exp. Immunol., 9 (1971) 305.PubMedGoogle Scholar
  18. 18.
    Schachat, D.A., Fefer, A. and Moloney, J.B., Cancer Res., 28 (1968) 517.Google Scholar
  19. 19.
    Simes, R.J., Kearney, R. and Nelson, D.S., Immunology, 29 (1975) 343.PubMedGoogle Scholar
  20. 20.
    Stutman, O., J. Immunol., 109 (1972) 602.PubMedGoogle Scholar
  21. 21.
    Stutman, O., Fed. Proc, 33 (1974) 2028.PubMedGoogle Scholar
  22. 22.
    Stutman, O., Ann. N. Y. Acad. Sci., 249 (1975) 89.PubMedCrossRefGoogle Scholar
  23. 23.
    Stutman, O., Nature, 253 (1975). 142.PubMedCrossRefGoogle Scholar
  24. 24.
    Stutman, O. and Good, R.A., Ser. Haematol., 7 (1974) 505.PubMedGoogle Scholar
  25. 25.
    Teague, P.O., Yunis, E.J., Rodey, G., Fish, A.J., Stutman, O. and Good, R.A., Lab. Invest., 22 (1970) 121.PubMedGoogle Scholar
  26. 26.
    Walford, R.L., Fed. Proc, 33 (1974) 2020.PubMedGoogle Scholar
  27. 27.
    Wigzell, H. and Stjernsward, J., J. Nat. Cancer Inst., 50 (1973) 701.Google Scholar
  28. 28.
    Yunis, E.J., Gernandez, G., Smith, J., Stutman, O. and Good, R.A., Microenvironmental Aspects of Immunity (Ed. B.D. Jankovic and K. Isakovic) Plenum Press, New York (1975) 301.Google Scholar
  29. 29.
    Zarling, J.M. and Tevethia, S.S., J. Nat. Cancer Inst., 50 (1973) 149.PubMedGoogle Scholar
  30. 30.
    Zbar, B., Wepsic, T.H., Rapp, H.J., Stewart, L.C. and Borsos, T., J. Nat. Cancer Inst., 44 (1970) 701.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1976

Authors and Affiliations

  • O. Stutman
    • 1
  1. 1.Memorial Sloan-Kettering Cancer CenterNew YorkUSA

Personalised recommendations